key: cord-0425837-bgo9qkc0
authors: Wang, Shuxia; Xu, Shuhang; Cao, Meng; Zhou, Jing; Mao, Xiaodong; Yao, Xiaoming; Liu, Chao
title: Luteolin transforms the BMDM polarity to regulate the expression of inflammatory factors
date: 2020-07-02
journal: bioRxiv
DOI: 10.1101/2020.06.30.181503
sha: 2e4779421f75f5363ddccd9ab28cace181c01ce6
doc_id: 425837
cord_uid: bgo9qkc0

Macrophage are indispensable regulator cells in inflammatory response. Macrophage polarization and its secreted inflammatory factors have affinity with the outcomes of inflammation. Luteolin, a flavonoid abundant in plants has anti-inflammatory activity, but whether luteolin can manipulate M1/M2 polarization of BMDM to suppress inflammation is still veiled. The purpose of this study was to observe the effects of luterolin on the polarity of BMDM derived from C57BL/6 mice and the expression of inflammatory factors, to explore the mechanism of luteolin regulating the BMDM polarity. M1-polarized BMDM were induced by LPS+IFN-γ, M2-polarization were stimulated with IL-4. BMDM morphology was observed by laser confocal microscopy; levels of BMDM differentiation and CD11c or CD206 on membrane surface were assessed by FCM; mRNA and protein of M1/M2-type inflammatory factors were performed by qPCR and ELISA, respectively; the expression of p-STAT1 and p-STAT6 protein pathways was detected by Western-blotting. The isolated mouse bone marrow cells were successfully differentiated into BMDM, LPS+IFN-γ induced BMDM M1-phenotype polarization, and IL-4 induced its M2-phenotype polarization. After M1-polarized BMDM treated with luteolin, M1-type pro-inflammatory factors including IL-6, TNF-α□iNOS, CD86 were down-regulated while M2-type anti-inflammatory factors including IL-10, Arg1, CD206 were up-regulated; the expression of M1-type surface marker CD11c decreased, nevertheless, M2-type marker CD206 increased; levels of inflammatory signaling protein p-STAT1 and p-STAT6 were attenuated and enhanced respectively. Our study suggests luteolin may transform BMDM polarity through p-STAT1/6 to regulate the expression of inflammatory mediators, thereby inhibiting inflammation. Naturally occurring luteolin hold promise as an anti-inflammatory and immunomodulatory agent.

and LPS plus IFN--primed cells were administrated with luteolin (Sigma, USA) at 2.5 and 5.0 108 mol/L for 24 h. Following treatment, cells were added with 20 μL MTT solution (5 mg/mL; 109 Sigma, MO. USA). 4 h later, culture medium was removed and crystals were dissolved with 150 110 μL/well DMSO. The absorption values were measured at 570 nm. 111

The morphology of polarized BMDM. BMDM in logarithmic stage were cultivated in 6-well 112 plates, and incubated overnight followed by treatment with LPS (20 ng/mL) plus IFN- (10 ng/mL) 113 or IL-4 (20 ng/mL). Simultaneously, the cells stimulated with LPS+IFN- were co-cultured with 114 specified concentrations of luteolin for 24 h. The cell morphology was observed under an inverted 115 microscope (Olympus, Japan). Cells and culture supernatants were collected for subsequent 116 mRNA and protein analysis. 117

Quantitative real-time PCR (qPCR). BMDM were stimulated with LPS plus IFN- or IL-4 118 respectively, following dosing stimuli, cells were collected and total RNA was extracted by Trizol 119 (Ambion Life Technology, USA) and reverse-transcribed into cDNA. With GAPDH as the 120 internal reference, qPCR was carried out using SYBR Green Master Mix (Toyobo, Japan) 121 according to primer sequences with Quant studio DX real-time quantitative PCR employed 122 biosystems (Life Technologies, USA). Relative gene expression was calculated using the 2 −ΔΔct 123 comparative method. Primer Sequences were obtained from Generay Biotech Co. Ltd. (Shanghai, 124 China) and listed in Table 1 . 125 antibodies with shaken at room temperature for 30 min. Immunoreactive proteins were exposed 145 and developed using ECL (Beyotime, China), and -actin was used as an internal reference to 146 calculate the relative expression of protein. corresponding LPS+IFN--treated group, there was a statistical difference (Fig. 6) . 220 group) in M1-polarized BMDM in a concentration-dependent pattern (Fig.7) . 237 Immunoblotting assay and densitometry analysis of STAT proteins revealed that M1-polarized lowly expresses p-STAT1 and highly expresses p-STAT6. Predominantly, after luteolin 250 contribution, p-STAT1 expression was depressed while p-STAT6 was strengthened in protein 251 pathway of M1-polarized BMDM (Fig. 8) . crucial cytokines IL-6 and TNF- generated abundantly by IL-1 stimulation or autocrine from 299 activated "mononuclear-macrophage system", are elevated not only in bacterial infection but also 300 during viral infection (23-24). More importantly, they are most strong pro-inflammatory agent 301 causing "cytokine storm". Studies have shown that patients with severe COVID-19 characterized 302 by a "cytokine storm" inexorably exhibited high levels of IL-6 and TNF-in serum, and IL-6 or 303 TNF- antagonist seems to be very promising for severe COVID-19 cases (25-26). 304

To our knowledge, IL-4 or IL-13 can induce M2-type polarization of macrophages, and M2-type anti-inflammatory factors such as IL-10, Arg1 and CD206 are up-modulated. In this 306 regard, IL-4 binds to its receptor to activate JAK to further phosphorylate STAT6 and enhance the 307 Arg1 activity. Arg1 and iNOS are important hallmarkers of M2/M1 type macrophage polarization, 308

respectively. Under normal circumstances, the activities of Arg1 and iNOS are strictly regulated 309 by macrophages and maintain a dynamic equilibrium. When M2 polarization occurs, Arg1 310 competes for iNOS to decompose substrate arginine, thus benefit for tissue regeneration. 311

Moreover, Arg1 is also inseparable from M2 macrophage properties in playing immune memory 312 function to eliminate infectious agents. CD206, so called mannose receptor, is a membrane surface 313 marker of M2 cells, which can specifically recognize antigens to clear pathogens, promote 314 angiogenesis and repress immune response (27). Another M2-type anti-inflammatory factor, IL-10, 315 on the one hand, enhances the sensitivity of macrophages to IL-4 and IL-13 by increasing the 316 abundance of IL-4 receptors on the macrophage surface, which contributes to M2-type 317 polarization of macrophages. On the other hand, it can synergize with IL-4 to inhibit 318 pro-inflammatory cytokines IL-1 and TNF- to reduce inflammation. In the light of preliminary 319 data, IL-10 displayed higher levels in patients with sepsis and serious COVID-19 (28). All these 320 indicate that when inflammation is motivated, an intricate network is formed between the 321 pro-inflammatory mediators and activated STAT1, eliciting "inflammatory storm." Nevertheless, 322 upon luteolin contribution, a complex network is also formed between anti-inflammatory 323 mediators and activated STAT6, further facilitating the expression of anti-inflammatory factors 324 which resist the formation of pro-inflammatory factors and alleviate inflammation accordingly. 325

Herbal compound Physalin D can repolarize M1 toward M2 polarization in BMDM through 326 STAT1 suppression and STAT6 activation (29), which consist with our study.

Altogether, BMDM polarization mechanism is complex and involves many protein 328 pathways. Only by actively exploring the regulation of BMDM polarization and maintaining the 329 balance of inflammatory mediators can maintain the physical stable. In this investigation, 330 LPS/IFN- induced M1 polarization and IL-4 induced M2 polarization of BMDM. After being 331 treated with herbal compound luteolin, the M1 polarized BMDM showed lowered M1-type 332 pro-inflammatory factors and elevated M2-type anti-inflammatory factor, and that signaling 333 protein p-STAT1 was down-regulated and P-STAT6 was up-regulated. That is, the macrophage 334 population underwent a transformation from a pro-inflammatory M1-phenotype to an 335 anti-inflammator M2-phenotype. Simultaneously, inflammatory factors analogously altered from 336 pro-inflammatory to anti-inflammatory. In light of these findings, our research provide a novel 337 insight into the role of luteolin to be a candidate for controlling macrophage phenotype to treat 338 infectious disease. 339

We acknowledge the support of their staff and Facility of department of Endocrine and 341

Metabolism in accomplishing this work. We also thank Dr. 

Cytokine storm and sepsis disease 351 pathogenesis

Inflammation and cancer: triggers, mechanisms, and 353 consequences

Melatonin as a potential adjuvant treatment

SARS-CoV-2 and viral 358 sepsis: observations and hypotheses

Immunomodulatory therapy for the 362 management of severe COVID-19. Beyond the anti-viral therapy: a comprehensive review

The cytokine storm of severe influenza and development of 365 immunomodulatory therapy

Effect of 367 luteolin on inflammatory responses in RAW264.7 macrophages activated with LPS and IFN-γ

Protective role of ACE2 and its downregulation 370

SARS-CoV-2 infection leading to macrophage activation syndrome: therapeutic implications

Apigenin and luteolin display differential 373 hypocholesterolemic mechanisms in mice fed a high-fat diet

Luteolin suppresses colorectal cancer cell metastasis 376 via regulation of the miR-384/pleiotrophin axis

Luteolin attenuates airway inflammation by inducing the transition of CD4(+)CD25(-) to

CD4(+)CD25(+) regulatory T cells

Luteolin decreases the yield 383 of influenza A virus in vitro by interfering with the coat protein I complex expression

Luteolin restricts dengue virus replication through inhibition of the proprotein convertase 387 furin

Review on the potential action mechanisms of 389 chinese medicines in treating coronavirus disease 2019 (COVID-19)

Immune-mediated cytokine storm and its 392 role in severe dengue

Amplification of the signal transducer and activator of transcription I signaling pathway and 395 its association with apoptosis in monocytes from HIV-infected patients

Signaling molecules involved in production and regulation of 398

Macrophage 401 polarization and function with emphasis on the evolving roles of coordinated regulation of cellular 402 signaling pathways

Metabolism via arginase or nitric oxide 404 synthase: two competing arginine pathways in macrophages

Preconditioning of bone 407 marrow-derived mesenchymal stem cells highly strengthens their potential to promote 408 IL-6-dependent M2b polarization

Functional IL-10 deficiency in the lung of 411 cystic fibrosis (cftr(-/-)) and IL-10 knockout mice causes increased expression and function of B7 412 costimulatory molecules on alveolar macrophages

CD11c/CD18 dominates adhesion of human monocytes, macrophages and dendritic cells 416 over CD11b/CD18

IL-1β Is a key cytokine that induces 418 trypsin upregulation in the influenza virus-cytokine-trypsin cycle

IL-6: relevance for 421 immunopathology of SARS-CoV-2

COVID-19, immune system response

hyperinflammation and repurposing antirheumatic drugs

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

Hepatic CD206-positive macrophages 430 express amphiregulin to promote the immunosuppressive activity of regulatory T cells in HBV 431 infection

Clinical features of patients infected with 2019 novel 435 coronavirus in Wuhan

Physalin D regulates macrophage M1/M2 polarization via the STAT1/6 pathway